Top compounds associated with response to CCDC94


Feature Type Standardized
Nominal ANOVA
mRNA Pyrimethamine GDSC1000 pan-cancer AAC 0.014 0.8
mRNA decitabine CTRPv2 pan-cancer AAC 0.0072 0.8
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.0098 0.8
mRNA SJ-172550 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.8
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA Tipifarnib FIMM pan-cancer AAC -0.034 0.8
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA istradefylline CTRPv2 pan-cancer AAC -0.014 0.8
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0085 0.8
Download CSV